Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Case 26 - “I Am a Worrier”

  • Matthew Gibfried, Saint Louis University School of Medicine, Missouri, George T. Grossberg, Saint Louis University School of Medicine, Missouri
  • Book:
    Clinical Case Studies in Long-Term Care Psychiatry
    Published online:
    31 October 2024
    Print publication:
    14 November 2024, pp 126-129

  • Summary

    Schizoaffective disorder is a psychiatric disorder in which patients demonstrate a combination of symptoms associated with schizophrenia and a mood disorder such as bipolar disorder or depression. The symptoms of schizophrenia and mood disorder occur concomitantly for a substantial portion of the illness duration. If a resident has been stable on a psychiatric drug regimen, it is advisable to avoid any major change because obtaining a similar good therapeutic response from a different drug regimen is not predictable or assured. All antipsychotics have the potential to cause weight gain and increase the risk of obesity and related hyperlipidemia and diabetes. Atypical antipsychotics can be thought of as being high, medium, and low risk for these complications. Antipsychotics thought to be low risk for metabolic syndrome include cariprazine, lurasidone, lumateperone, ziprasidone, pimavanserin, aripiprazole, and brexpiprazole.